» Articles » PMID: 26182326

Successful Treatment of Advanced Gastric Adenocarcinoma with Portal Tumor Thrombosis by Total Gastrectomy Following CDDP and S-1 Therapy

Overview
Specialty Gastroenterology
Date 2015 Jul 17
PMID 26182326
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Gastric cancers with portal tumor thrombosis (GCPTs) are a rare entity, often concomitant with hematogenous metastases, and chemotherapy is mainly used to treat them. However, the outcome of GCPT is reported to be dismal. We experienced a case of GCPT with splenic metastases. A 53-year-old man was admitted for anorexia. Upper gastrointestinal scope revealed type 3 gastric cancer of the stomach. Abdominal computed tomography showed a huge tumor thrombus in the splenic vein extending to the hepatic hilus and multiple metastases to the spleen. S-1 was given orally from day 1 to day 21 and 60 mg of CDDP was administered intravenously. The cancerous thrombosis in the portal system and splenic metastases disappeared due to chemotherapy. Total gastrectomy with lymphadenectomy and splenectomy was carried out with curative intent after 10 courses of chemotherapy. Intraoperatively, no tumor thrombosis was identified and the gastric tumor was surgically removed. After surgery, the patient received adjuvant chemotherapy of S-1. After 6 months he is well and has not suffered from tumor relapse. A combination of CDDP + S-1 plus intervention surgery seems to be a promising option for GCPT.

Citing Articles

Minimally Invasive Conversion Surgery for Unresectable Gastric Cancer with Splenic Metastasis and Splenic Vein Tumor Thrombus: A Case Report.

Tanioka N, Kuwahara M, Sakai T, Nokubo Y, Shimizu S, Hiroi M Curr Oncol. 2024; 31(5):2662-2669.

PMID: 38785482 PMC: 11119725. DOI: 10.3390/curroncol31050201.


Isolated Superior Mesenteric Vein Tumor Thrombus in a Patient with Gastric Cancer.

Ozcan B, Cevener M, Kargi A, Ozdogan M, Gurkan A Case Rep Surg. 2018; 2018:3648436.

PMID: 29780653 PMC: 5892258. DOI: 10.1155/2018/3648436.


Long-Term Survival of a Patient with Adenocarcinoma of the Esophagogastric Junction with a Portal Vein Tumor Thrombosis Who Underwent Palliative Total Gastrectomy: A Case Report.

Oh S, Oh S, Suh B, Shin J, Park J Case Rep Oncol. 2017; 10(3):916-922.

PMID: 29279692 PMC: 5731138. DOI: 10.1159/000481430.


A long-surviving case of gastric cancer with main portal vein tumor thrombus after surgical resection and postoperative S-1 therapy.

Sato S, Nagai E, Taki Y, Watanabe M, Takahashi M, Kyoden Y Clin J Gastroenterol. 2016; 9(4):233-7.

PMID: 27318995 DOI: 10.1007/s12328-016-0665-4.

References
1.
Ishigami S, Natsugoe S, Nakajo A, Matsumoto M, Uenosono Y, Arigami T . Salvage gastrectomy following a combination of biweekly paclitaxel and S-1 for stage IV gastric cancer. J Gastrointest Surg. 2008; 12(8):1370-5. DOI: 10.1007/s11605-008-0539-2. View

2.
Shalev T, Guranda L, Shovman O, Michael L . Microscopic pulmonary tumor embolism in adenocarcinoma of the stomach. Isr Med Assoc J. 2004; 6(6):374-5. View

3.
Hoshimoto S, Hagiuda J, Igarashi N, Matsui H, Koyama Y, Miyakita M . [A case of advanced gastric cancer with a tumor embolus in the portal vein successfully treated with TS-1 and CDDP]. Gan To Kagaku Ryoho. 2004; 31(7):1079-81. View

4.
Tanaka A, Takeda R, Mukaihara S, Hayakawa K, Takasu K, Terajima H . Tumor thrombi in the portal vein system originating from gastrointestinal tract cancer. J Gastroenterol. 2002; 37(3):220-8. DOI: 10.1007/s005350200025. View

5.
Koizumi W, Kurihara M, Nakano S, Hasegawa K . Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group. Oncology. 2000; 58(3):191-7. DOI: 10.1159/000012099. View